Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-018940
Filing Date
2022-08-04
Accepted
2022-08-04 17:16:25
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q siga20220525_10q.htm   iXBRL 10-Q 819993
2 EXHIBIT 31.1 ex_380347.htm EX-31.1 15598
3 EXHIBIT 31.2 ex_380348.htm EX-31.2 15709
4 EXHIBIT 32.1 ex_380349.htm EX-32.1 6027
5 EXHIBIT 32.2 ex_380350.htm EX-32.2 5908
  Complete submission text file 0001437749-22-018940.txt   5043784

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA siga-20220630.xsd EX-101.SCH 58055
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE siga-20220630_cal.xml EX-101.CAL 35377
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE siga-20220630_def.xml EX-101.DEF 320395
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20220630_lab.xml EX-101.LAB 294913
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20220630_pre.xml EX-101.PRE 347978
61 EXTRACTED XBRL INSTANCE DOCUMENT siga20220525_10q_htm.xml XML 862754
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38436 | Film No.: 221137747
SIC: 2834 Pharmaceutical Preparations